President Donald Trump’s nominee for FDA Commissioner, Martin A. Makary, MD, sought to assure senators that if confirmed, he would support efforts to expedite reviews of new drugs indicted for rare ...

Stock analysts at BMO Capital Markets started coverage on shares of Dyne Therapeutics (NASDAQ:DYN – Get Free Report) in a ...

Dyne Therapeutics (DYN) stock gains premarket momentum as BMO Capital Markets issus a new Outperform rating on the company. Read more here.

A live webcast will be available in the Investors & Media section of Dyne’s website at https://investors.dyne-tx.com/news-and-events/events-and-presentations and a replay will be accessible for 90 ...

Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.

The Diginex team celebrates a historic milestone at Times Square, New York, after ringing the Nasdaq Closing Bell on March 6, ...

On Friday, H.C. Wainwright analyst Andrew Fein adjusted the price target for Dyne Therapeutics (NASDAQ:DYN) to $46 from $55, while... On Friday, Piper Sandler adjusted its financial outlook on ...

2-Year U.S. Treasury Note Continuous Contract $103.551 0.086 0.08% 5-Year U.S. Treasury Note Continuous Contract $107.930 0.203 0.19% 10-Year U.S. Treasury Note Continuous Contract $110.922 0.281 ...

The NASDAQ refers to the National Association of Securities Dealers Automated Quotations exchange. It was the world’s first all-electronic stock exchange and is subject to the regulatory ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...